| Section | Provisional content |
|---|---|
| Retrieval / citation status | No citable contexts were retrievable in this session, so this report is seed-only, provisional, and requires manual verification against the seed PubMed records before curation use. |
| Executive judgment | **Partially supported (provisional).** The seed evidence is consistent with biallelic or otherwise damaging **SYCE1** variants causing meiotic failure through synaptonemal-complex dysfunction, but confidence is limited because the underlying papers were not retrievable for direct verification in this run. |
| Evidence sources with PubMed URLs | **PMID:25062452** — https://pubmed.ncbi.nlm.nih.gov/25062452/ — familial human POI/primary amenorrhea with homozygous nonsense SYCE1 variant; **PMID:32402064** — https://pubmed.ncbi.nlm.nih.gov/32402064/ — model evidence for absent/reduced SYCE1 and synapsis-related infertility mechanism; **PMID:34718620** — https://pubmed.ncbi.nlm.nih.gov/34718620/ — SYCE1 variants reported to disrupt interaction with **SYCP1** and/or **C14ORF39/SIX6OS1**, affecting SC assembly; **PMID:35718780** — https://pubmed.ncbi.nlm.nih.gov/35718780/ — human NOA cases with SYCE1 CNVs and pachytene-stage arrest on H&E/IF. |
| Clinical spectrum by sex | **46,XX:** primary ovarian insufficiency / primary amenorrhea. **46,XY:** non-obstructive azoospermia with reported pachytene-stage spermatogenic arrest. Detailed endocrine data (e.g., FSH/AMH), ovarian imaging, follicle depletion, semen parameters, and full biopsy marker panels were not retrievable here. |
| Variants / inheritance | Provisional inheritance model: **autosomal recessive / biallelic**. Seed evidence mentions a **homozygous nonsense variant c.613C>T**, additional damaging variants affecting SYCE1 interactions, and **SYCE1 CNVs** in NOA. Exact zygosity/phasing, family counts, CNV breakpoints, segregation details, and ACMG/ClinVar classifications require manual verification. |
| Mechanism chain | Provisional chain: **biallelic SYCE1 loss/damaging variant → reduced or absent SYCE1 → disrupted interaction with SYCP1 and/or C14ORF39/SIX6OS1 → synaptonemal-complex central element assembly failure → homologous chromosome synapsis failure during meiotic prophase I → pachytene arrest/checkpoint activation → germ-cell depletion → 46,XX POI/primary amenorrhea or 46,XY NOA/spermatogenic arrest**. Human support appears strongest for phenotype and arrest endpoints; several intermediate steps likely rely on model or in vitro evidence. |
| Diagnostics / management | Provisional implications: include **SYCE1** on infertility/POI/NOA genetic testing panels with **CNV detection**; in 46,XY consider semen analysis, endocrine evaluation, and biopsy when indicated; in 46,XX assess ovarian reserve and POI biochemistry. Management likely follows standard POI/NOA care pathways, including hormone replacement for POI as indicated, fertility counseling, donor-oocyte discussion, and cautious consideration of micro-TESE/ICSI in NOA. |
| Ontology suggestions | **HPO:** Primary ovarian insufficiency; Primary amenorrhea; Female infertility; Azoospermia; Non-obstructive azoospermia; Spermatogenic arrest; Hypergonadotropic hypogonadism. **GO:** Meiotic cell cycle; Homologous chromosome pairing; Synaptonemal complex assembly; Meiotic recombination; Germ cell apoptotic process. **CL:** Primary oocyte; Spermatocyte; Pachytene spermatocyte; Germ cell. **Treatment/action terms:** Genetic testing; Genetic counseling; Hormone replacement therapy; Fertility preservation; Oocyte cryopreservation; Micro-TESE; ICSI; PGT-M. |
| Gaps | Major gaps reflect the retrieval block: no full-text verification, no figure/table access, no confirmed hormone values or detailed histology, uncertain CNV zygosity/phasing, and limited ability to distinguish direct human evidence from mouse or in vitro inference. Direct evidence for checkpoint activation or apoptosis in human tissue remains especially uncertain. No newer 2023–2024 studies could be identified or prioritized in this environment. |
| Curator leads | After direct review of the seed PMIDs, consider updating the entry to note: (1) a core mechanism of **meiotic synaptonemal-complex central element assembly defect**; (2) dual-sex phenotype of **46,XX POI/primary amenorrhea** and **46,XY NOA/pachytene arrest**; (3) support for **loss-of-function and CNV** mechanisms; and (4) a partner-interaction mechanism involving **SYCP1** and **C14ORF39/SIX6OS1**. |


*Table: This table provides a concise seed-only summary of the mechanistic hypothesis for SYCE1-related gametogenic failure. It is useful as a curation placeholder when no retrievable citable contexts were available in the session.*